Salarius Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/14/2022 | 1.35 M | $264.00 K | -14.61% | 2.41% |
| RENAISSANCE TECHNOLOGIES LLC | 11/14/2022 | 634.26 K | $124.00 K | 17.88% | 1.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/14/2022 | 413.14 K | $80.00 K | 0.00% | 0.74% |
| TWO SIGMA ADVISERS, LP | 11/14/2022 | 310.00 K | $60.00 K | -4.97% | 0.55% |
| STATE STREET CORP | 11/15/2022 | 142.55 K | $28.00 K | 0.00% | 0.25% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2022 | 115.68 K | $23.00 K | -60.37% | 0.21% |
| X-SQUARE CAPITAL, LLC | 11/04/2022 | 89.00 K | $17.00 K | 0.00% | 0.16% |
| NORTHERN TRUST CORP | 11/14/2022 | 65.02 K | $13.00 K | 0.00% | 0.12% |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 11/15/2022 | 60.00 K | $12.00 K | 50.00% | 0.11% |
| UBS GROUP AG | 11/10/2022 | 40.85 K | $8.00 K | -3.40% | 0.07% |
| WETHERBY ASSET MANAGEMENT INC | 11/14/2022 | 39.75 K | $8.00 K | 0.00% | 0.07% |
| BANK OF NEW YORK MELLON CORP | 11/14/2022 | 35.27 K | $7.00 K | 0.00% | 0.06% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2022 | 34.70 K | $6.00 K | -0.01% | 0.06% |
| ERN FINANCIAL, LLC | 11/14/2022 | 32.05 K | $6.00 K | 0.00% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/10/2022 | 24.09 K | $5.00 K | -69.59% | 0.04% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 10/17/2022 | 21.29 K | $4.00 K | 0.00% | 0.04% |
| TWO SIGMA SECURITIES, LLC | 11/14/2022 | 12.19 K | $2.00 K | -21.35% | 0.02% |
| LPL FINANCIAL LLC | 11/14/2022 | 10.02 K | $2.00 K | 0.00% | 0.02% |
| MORGAN STANLEY | 11/14/2022 | 1.50 K | $0 | 0.13% | 0.00% |
| BLACKROCK INC. | 11/14/2022 | 1.20 K | $0 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/14/2022 | 350 | $0 | -6.67% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 11/15/2022 | 0 | $0 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| HIGHTOWER ADVISORS, LLC | 11/09/2022 | 0 | $0 | -100.00% | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 11/16/2022 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/07/2022 | 0 | $0 | -100.00% | 0.00% |
| FINANCIAL ADVOCATES INVESTMENT MANAGEMENT | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Salarius Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Salarius Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Advisor Group, Inc.: 1,900
LADENBURG THALMANN FINANCIAL SERVICES INC.: 4
6.11% of Salarius Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.90 K shares in the last 24 months. This purchase volume represents approximately $1.47 K in transactions.